Last reviewed · How we verify
Basal
At a glance
| Generic name | Basal |
|---|---|
| Also known as | continuous basal infusion |
| Sponsor | University of California, San Diego |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Effect of the DASH Diet on Treatment Outcomes in Adults Diagnosed With Rheumatoid Arthritis (NA)
- How to Bathe a Person With Dementia? A Bathing Intervention Based on Basale Stimulation® for People With Moderate to Severe Dementia (NA)
- Glycemic Variability Comparing Two vs Five Meals in Type 2 Diabetes (NA)
- FLASH Radiotherapy for Skin Cancer (NA)
- Cortical-Basal Ganglia Speech Networks (NA)
- Tritordeum-based Foods for IBS Symptoms (NA)
- Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery (PHASE2)
- Surgical or Medical Treatment (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Basal CI brief — competitive landscape report
- Basal updates RSS · CI watch RSS
- University of California, San Diego portfolio CI